Research Article
Extracorporeal Immunoglobulin Elimination for the Treatment of Severe Myasthenia Gravis
Table 1
Basic clinical data. Number of myasthenic crises experienced requiring artificial ventilation: + = 1-2, ++ = 2–5, +++ = more than 5. IA = immunotherapy, Mes: Mestinon, M: Medrol, P: Prednison, CC: CellCept, Pr: Prograf.
| Patient no. | Classification (MGFA) | Age | Sex | Myasthen. crises | Therapy duration | Current condition | Current therapy |
| 1 | III b | 35 | F | ++ | 13 | Excellent, IA therapy stopped | Mes | 2 | IV b | 33 | F | + | 13 | Stabilization, IA therapy stopped | Mes | 3 | IV b | 65 | F | +++ | 96 | Stabilization | Mes, M, CC, IVIG | 4 | IV b | 28 | F | +++ | 76 | Stabilization | Mes, P, Pr | 5 | III b | 53 | F | + | 79 | Stabilization | Mes, P, CC, IVIG | 6 | IV b | 60 | F | ++ | 62 | Stabilization | Mes, P, CC |
|
|